Assignee
JANSSEN PHARMACEUTICALS INC
US·120 granted patents·97 pending applications·552 citations·filing 2005–2025
Top patents by PatentIndex Score
217 records- 0196US11364310B2Recombinant virus replicon systems and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 21, 2022·12 cites·18 claims
- 0296US11266627B1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Mar 8, 2022·12 cites·30 claims
- 0395US11998525B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Jun 4, 2024·5 cites·29 claims
- 0495USD956215SAutoinjectorJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Jun 28, 2022·19 cites·1 claims
- 0595US10919854B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·3 cites·28 claims
- 0695USD903108SGrip accessory for a manual injection deviceJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 24, 2020·19 cites·1 claims
- 0795US9944598B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Apr 17, 2018·21 cites·17 claims
- 0895US9605082B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·11 cites·24 claims
- 0994US12150929B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Nov 26, 2024·2 cites·19 claims
- 1094US11827602B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 28, 2023·2 cites·11 claims
- 1194US11083786B2Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·13 cites·24 claims
- 1294US11033633B2ExPEC glycoconjugate vaccine formulationsJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Jun 15, 2021·11 cites·20 claims
- 1394US10029984B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·21 cites·5 claims
- 1493US12161622B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Dec 10, 2024·2 cites·29 claims
- 1593US11607216B2Adaptive responses from smart packaging of drug delivery absorbable adjunctsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Mar 21, 2023·4 cites·26 claims
- 1693US11498944B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Nov 15, 2022·10 cites·28 claims
- 1793US8399493B2Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptorsJANSSEN PHARMACEUTICALS INC·Filed 2005·Granted Mar 19, 2013·50 cites·9 claims
- 1892US11446370B2Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·6 cites·42 claims
- 1992US11421003B2FimH mutant, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Aug 23, 2022·4 cites·25 claims
- 2092US11124552B2Compositions of phosphorylated tau peptides and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Sep 21, 2021·8 cites·14 claims
- 2192USD902392SGrip accessory for a manual injection deviceJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·13 cites·1 claims
- 2292US10206902B2Mono- or di-substituted indoles as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Feb 19, 2019·14 cites·9 claims
- 2392US10159751B2ExPEC glycoconjugate vaccine formulationsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Dec 25, 2018·16 cites·20 claims
- 2492US9981950B2Triazoles as NR2B receptor inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted May 29, 2018·17 cites·28 claims
- 2592US9518128B2Thrombin-binding antibody moleculesJANSSEN PHARMACEUTICALS INC·Filed 2014·Granted Dec 13, 2016·10 cites·27 claims
- 2691US12012435B2FimH mutant, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Jun 18, 2024·2 cites·15 claims
- 2791US11844766B2ExPEC glycoconjugate vaccine formulationsJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Dec 19, 2023·2 cites·22 claims
- 2891US11384122B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Jul 12, 2022·2 cites·30 claims
- 2991US10696632B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jun 30, 2020·3 cites·13 claims
- 3091US10525145B2ExPEC glycoconjugate vaccine formulationsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jan 7, 2020·11 cites·30 claims
- 3191US10323021B2Triazoles as NR2B receptor inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jun 18, 2019·13 cites·32 claims
- 3290US11725028B2FimH mutants, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Aug 15, 2023·3 cites·33 claims
- 3390USD946141SAutoinjectorJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Mar 15, 2022·27 cites·1 claims
- 3490USD902391SGrip accessory for a manual injection deviceJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·11 cites·1 claims
- 3590US10538786B2Recombinant arterivirus replicon systems and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jan 21, 2020·14 cites·28 claims
- 3689US11180450B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 23, 2021·2 cites·3 claims
- 3789US10689340B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 23, 2020·4 cites·8 claims
- 3889US10155727B2PyrazolesJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Dec 18, 2018·15 cites·32 claims
- 3989US10143693B2Dosing regimen for missed doses for long-acting injectable paliperidone estersJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Dec 4, 2018·31 cites·29 claims
- 4088US12419859B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Sep 23, 2025·0 cites·7 claims
- 4188US12172959B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·0 cites·27 claims
- 4288US11591377B2Heterologous administration of tau vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Feb 28, 2023·2 cites·20 claims
- 4388US9988461B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 5, 2018·3 cites·31 claims
- 4488US9518129B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2012·Granted Dec 13, 2016·9 cites·25 claims
- 4588US2025230127A1Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4687US11826416B2Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·1 cites·24 claims
- 4785US12173025B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Dec 24, 2024·0 cites·8 claims
- 4885US11931405B2Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Mar 19, 2024·1 cites·22 claims
- 4984US11707440B2Esketamine for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jul 25, 2023·4 cites·17 claims
- 5084US9988463B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jun 5, 2018·3 cites·21 claims
Showing the top 50 of 217 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when JANSSEN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →